Skip to main content
. 2018 Oct 17;41(1):77–86. doi: 10.3892/or.2018.6803

Figure 5.

Figure 5.

Antitumor efficacy of osimertinib combined with IR in the NCI-H1975 ×enograft models. (A) Tumor growth curves. *P<0.05 vs. IR alone. (B) Tumor volume 25 days following the final day of treatment. *P<0.05, as indicated. (C) Changes in body weight over the study period. IR, irradiation.